Earlier Autism Diagnosis Possible for Some Children Based on Metabolic Biomarkers in Blood, New Research Shows
Sep 6, 2018A paper by NeuroPointDX scientists, along with our collaborator Dr. David Amaral (University of California – Davis MIND Institute), published in Biological Psychiatry, is the first publication resulting from the Children’s Autism Metabolome Project (CAMP), the largest study of the metabolism of children with autism spectrum disorder. Thomas Frazier, Chief Scientific Officer of Autism Speaks,
Stemina to Present Poster at Teratology Society Annual Meeting
Jun 15, 2018Stemina’s Jessica Palmer to Present Poster at Teratology Society Annual Meeting Jessica Palmer, Stemina’s Associate Director of Toxicology, will present a poster at the Teratology Society Annual Meeting, held June 23-27, 2018 in Clearwater, Florida. Anyone interested in developmental toxicity assays is encouraged to attend. A Human Pluripotent Stem Cell-Based Assay Accurately Predicts the Developmental
Stemina Launches Cardiotoxicity Assay, Presents Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2018
Feb 20, 2018Stemina Launches Cardiotoxicity Assay, Presents Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2018 The Stemina team will attend the Society of Toxicology’s Annual Meeting and ToxExpo in San Antonio, Texas from March 11-15, 2018. We are excited to share information about our new cardiotoxicity assay, Cardio quickPredict, now commercially-available for the first time.